Biotech RadarJobs updated

COMPANY

Sense Diagnostics, LLC

HQ: Cincinnati, OH source · senseneuro.com ↗

Also known as Sense Diagnostics · 5 sources

Location: Cincinnati, OH · source · Nov 29, 2023

Profile checked Oct 10, 2026

Keywords: Traumatic Brain Injury Intracranial Hemorrhages Intracerebral Hemorrhage Acute Stroke Stroke Hemorrhagic Hemorrhagic Stroke Ischemic Stroke SDx3

5Trials (company is sponsor)

Timeline

  1. Trial start —: A Study to Evaluate the SENSE Device's Ability to Detect TBI source ↗
  2. Trial start —: A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury source ↗
  3. Trial start Not phased (device or behavioral study): Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage source ↗
  4. Trial start Not phased (device or behavioral study): Early Feasibility Study of the SENSE Device source ↗
  5. Trial start Not phased (device or behavioral study): A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage source ↗

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT06828107A Study to Evaluate the SENSE Device's Ability to Detect TBINot listedRecruitingJul 11, 2025May 30, 2026 (estimated)
NCT05155800A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain InjuryNot listedCompletedDec 28, 2021Oct 17, 2023 (actual)
NCT04642443Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial HemorrhageNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Dec 23, 2020Jun 30, 2024 (estimated)
NCT03038087A Study to Test the SENSE Device in Patients With Intracranial HemorrhageNot phased (device or behavioral study)CompletedFeb 23, 2017Dec 31, 2017 (actual)
NCT03827720Early Feasibility Study of the SENSE DeviceNot phased (device or behavioral study)CompletedJun 6, 2019Nov 19, 2020 (actual)
Feedback